ArticleCirculation reports2021

Safety of Intravenous Autologous Bone Marrow-Derived Mesenchymal Cell Transplantation in 5 Patients With Reduced Left Ventricular Ejection Fraction.

Yukihito Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.